Showing 202 results

Filters Content type: News, Editors' picks, About HIV Topic: Injectable & long-acting PrEP

The antiretroviral drug cabotegavir, administered every eight weeks as an injection, has been shown to be safe and effective in preventing HIV infection in men who have sex with men. Studies in women are ongoing and scientists are also working on a long-acting PrEP implant.

Overcoming the Challenges of Adhering to Injectable ART and PrEP

Editor's pick
Infectious Disease Special Edition
26 June 2024